Ivan Vesely Email & Phone Number

Padua, Veneto, Italy

Padua, Veneto, Italy

Washington D.C. Metro Area

Expert Witness in Patent Litigation:I have acted as an expert witness in patent litigation in 4 major lawsuits between large heart valve companies. Experienced in cross-examination tactics.Advise Start-up Companies:I help early stage heart valve companies navigate the regulatory process from the bench testing to First In Human implants.

Dublin, Ireland

Responsible for leading a team of engineers to develop a temporary First in Human implant version of the CroiValve tricuspid valve therapy concept. Conceived of and directed the development of a novel Nitinol based coaptation valve frame design, and a delivery catheter system for the company's permanent implant system.

BSI is the leading provider of CE Mark Certification Services for Medical Devices. My background in Heart Valve technologies contributes to the overall expertise of the Vascular group with respect to new product design review and CE Mark certification.

Victoria, Canada

ViVitro Labs offers cardiovascular test equipment and related laboratory testing and consulting services in the growing cardiovascular technology space.

Greater Denver Area

Responsible for all company operations, fund-raising and market roll-out of a novel bioprosthetic heart valve• Led a new fundraising program targeting angel investors and angel groups, medical device distributors and corporate partners. Raised $1.8 million from new and repeat investors via a Series B preferred stock offering• Orchestrated a strategy for negotiating with Notified Body to establish the parameters for a clinical trial restart towards rapid awarding of CE Mark. Made use of statistical based arguments to arrive at a written agreement from Notified Body• Established a new network of international medical device distributors for product registration, sales and distribution and financial investment in the Company.• Launched an Equity Crowd Funding initiative with Poliwogg.com to complete the Series B round

Greater Denver Area

ValveXchange Inc. (“VXi”) is dedicated to improving the lives of patients requiring heart valve replacements. VXi holds patented technology on a two-piece bioprosthetic tissue valve that resolves the long standing compromises between conventional mechanical and tissue heart valves. VXI is currently funded by private investment capital and is in the midst of a European Clinical Trial

Los Angeles Metropolitan Area

Director of a basic and applied research at The Children’s Hospital, Los Angeles in Cardiovascular Medicine, with activities ranging from soft tissue biomechanics, to collagen- based tissue engineering, cardiac developmental biology and xenotransplantation. Took over the leadership of a struggling academic research group, refocused activities through internal expansion and collaboration with other programs at the Saban Institute.

Directed a growing Cardiovascular Research Program at the Childrens Hospital Los Angeles

Founded and directed the worlds largest, most well-funded heart valve research laboratory. Activities ranged from soft tissue mechanics, to computational modelling to tissue engineering.